These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39150397)

  • 1. Nrf2 Ameliorates Atrial Fibrosis During Antithrombotic Therapy for Atrial Fibrillation by Modulating CYP2C9 Activity.
    Wu L; Li Z; Xu L; Fan Y; Mao D; Sun H; Zhuang W
    J Cardiovasc Pharmacol; 2024 Oct; 84(4):440-450. PubMed ID: 39150397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.
    Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C
    J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes from Bone Marrow Mesenchymal Stem Cells with Overexpressed Nrf2 Inhibit Cardiac Fibrosis in Rats with Atrial Fibrillation.
    Xu L; Fan Y; Wu L; Zhang C; Chu M; Wang Y; Zhuang W
    Cardiovasc Ther; 2022; 2022():2687807. PubMed ID: 35360547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.
    Qiu H; Wu H; Ma J; Cao H; Huang L; Qiu W; Peng Y; Ding C
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):323-334. PubMed ID: 29290021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms.
    Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y
    Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑101a‑3p overexpression prevents acetylcholine‑CaCl
    Zhu J; Zhu N; Xu J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties.
    Ma J; Ma S; Yin C; Wu H
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
    Park YK; Lee MJ; Kim JH; Lee JS; Park RW; Kim GM; Chung CS; Lee KH; Kim JS; Lee SY; Bang OY
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1383-1390. PubMed ID: 28412319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
    Rahmutula D; Zhang H; Wilson EE; Olgin JE
    Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
    Wang D; Sun L; Zhang G; Liu Y; Liang Z; Zhao J; Yin S; Su M; Zhang S; Wei Y; Liu H; Liang D; Li Y
    Cardiovasc Toxicol; 2021 Mar; 21(3):192-205. PubMed ID: 33099748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
    Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y
    Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sox9 on TGF-β1-mediated atrial fibrosis.
    Wang H; Chen Y; Zhao S; Wang X; Lu K; Xiao H
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1450-1458. PubMed ID: 34596216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/smad2/3 signalling pathway.
    Hu HJ; Wang XH; Zhang ZZ; Ou Y; Ning ZH; Yang JY; Huang H; Tang HF; Jiang ZS
    Eur J Pharmacol; 2024 Nov; 982():176900. PubMed ID: 39168432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Nrf2/HO-1 and NF-κB/TNF-α signaling pathways with empagliflozin protects against atrial fibrillation-induced acute kidney injury in rats.
    Badreldin H; El-Karef A; Ibrahim T; Elshal M
    Toxicology; 2024 Aug; 506():153879. PubMed ID: 38971551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-β1.
    Choi EK; Chang PC; Lee YS; Lin SF; Zhu W; Maruyama M; Fishbein MC; Chen Z; Rubart-von der Lohe M; Field LJ; Chen PS
    Circ J; 2012; 76(6):1354-62. PubMed ID: 22447020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
    Chen W; Wu L; Liu X; Shen Y; Liang Y; Zhu J; Tan H; Yang Y; Liu Q; Wang M; Liu L; Wang X
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):126-132. PubMed ID: 27117036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
    Jiang XX; Zhang R; Wang HS
    Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillation.
    Zhou T; Wang Z; Fan J; Chen S; Tan Z; Yang H; Yin Y
    J Am Heart Assoc; 2015 Mar; 4(3):e001530. PubMed ID: 25792125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.